Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF
April 29, 2002
- Mr Nordhoff Talks about Prospects of Gen-Probe
April 29, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 29, 2002
- PhRMA Japan Representative Discusses AIDS in Developing Countries
April 29, 2002
- BI to Introduce Int'l Strategic Products into Japan
April 29, 2002
- Aventis, Fujisawa Form Alliance for Marketing of Synercid Injection
April 29, 2002
- Korosho to Beef Up Measures to Ensure Medical Safety
April 29, 2002
- SSP Licenses Spelear to Han All Pharm in South Korea
April 29, 2002
- Medical Facilities Run by Profit-making Firms to Be Discussed Again
April 29, 2002
- Vital-Net, Ohmori Yakuhin Tohoku to Merge in July
April 29, 2002
- Tokai Univ. Initiates Drug Discovery Project
April 29, 2002
- Animal Study Contracts Increasing: Huntingdon Life Sciences
April 29, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
April 29, 2002
- BUSINESS NEWS IN BRIEF
April 29, 2002
- Tokyo Katei Yakko Proposes New Distribution for Home Remedies
April 29, 2002
- WEBSITE NEWS
April 29, 2002
- LIFE Corporation to Expand Health Food Product Line
April 29, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
April 29, 2002
- NPO to Be Inaugurated to Promote Self-medication
April 29, 2002
- Kusuri Proverbs Reveal Japanese Spirit (8)
April 29, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…